Molecular stool screening for colorectal cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  British Journal of Surgery

• Publication date

  2004-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/bjs.4576PMID 15227685
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hereditary Nonpolyposis Colorectal Cancer ( HNPCC )

  2006cited by this paper
• Detection of APC mutations in fecal DNA from patients with colorectal tumors.

  2002cited by this paper
• Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool.

  2002cited by this paper
• Detection and diagnosis of blood in feces and urine: an overview.

  2002cited by this paper
• A simple method of detecting K-ras point mutations in stool samples for colorectal cancer screening using one-step polymerase chain reaction/restriction fragment length polymorphism analysis.

  2002cited by this paper
• Detection of proximal colorectal cancers through analysis of faecal DNA.

  2002cited by this paper
• Stool-based DNA tests for colorectal cancer: clinical potential and early results.

  2002cited by this paper
• Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-->T:A mutations.

  2002cited by this paper
• MR colonography with barium-based fecal tagging: initial clinical experience.

  2002cited by this paper
• Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors

  2002cited by this paper
• CT colonography (virtual colonoscopy) for the detection of colorectal polyps and neoplasms. current status and future developments.

  2002cited by this paper
• Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system.

  2002cited by this paper
• Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening

  2001cited by this paper
• Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer.

  2001cited by this paper
• Piffalls in diagnostic molecular pathology--significance of sampling error.

  2001cited by this paper
• Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer

  2001cited by this paper
• Multiple detection of genetic alterations in tumors and stool.

  2001cited by this paper
• A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.

  2001cited by this paper
• PCR-based detection of genetically modified soybean and maize in raw and highly processed foodstuffs.

  2001cited by this paper
• Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study

  2001cited by this paper
• Measuring interval cancers in population‐based screening using different assays of fecal occult blood testing: The district of Florence experience

  2001cited by this paper
• Screening of First Degree Relatives of Patients Operated for Colorectal Cancer: Evaluation of Fecal Calprotectin vs. Hemoccult II

  2001cited by this paper
• Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC).

  2001cited by this paper
• Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma

  2001cited by this paper
• Apoptosis (programmed cell death) in colonic cells: from normal to transformed stage.

  2001cited by this paper
• Detecting colorectal cancer in stool with the use of multiple genetic targets.

  2001cited by this paper
• Current trends in colorectal cancer: site, incidence, mortality and survival in England and Wales.

  2001cited by this paper
• Pitfalls in diagnostic molecular pathology – significance of sampling error

  2001cited by this paper
• A highly sensitive method for K-ras mutation detection is useful in diagnosis of gastrointestinal cancer.

  2000cited by this paper
• New protocol for DNA extraction of stool.

  2000cited by this paper
• Molecular Genetics of Hereditary Nonpolyposis Colorectal Cancer

  2000cited by this paper
• The role of hypermethylation of thehMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers

  2000cited by this paper
• Quantitation of DNA extracted after micropreparation of cells from frozen and formalin-fixed tissue sections.

  2000cited by this paper
• Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.

  2000cited by this paper
• Morphometric analysis of the "mucocellular layer" overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening.

  2000cited by this paper
• Hereditary nonpolyposis colorectal cancer (HNPCC)

  1999cited by this paper
• Genetic epidemiology of mutated K-rasproto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas

  1999cited by this paper
• DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer?

  1999cited by this paper
• Direct Detection of Shiga Toxigenic Escherichia coliStrains Belonging to Serogroups O111, O157, and O113 by Multiplex PCR

  1999cited by this paper
• Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces

  1999cited by this paper
• Twenty years of p53 research: structural and functional aspects of the p53 protein

  1999cited by this paper
• An update on Lynch syndrome.

  1998cited by this paper
• Detection of APC mutations in stool DNA of patients with colorectal cancer by HD‐PCR

  1998cited by this paper
• Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer.

  1998cited by this paper
• Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas.

  1998cited by this paper
• Tumor-suppressor p53: implications for tumor development and prognosis.

  1998cited by this paper
• Fecal calprotectin concentration in patients with colorectal carcinoma

  1998cited by this paper
• Genetic pathways to colorectal cancer.

  1997cited by this paper
• Colorectal cancer screening: clinical guidelines and rationale.

  1997cited by this paper
• Microsatellite instability in colorectal adenomas.

  1997cited by this paper
• K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.

  1997cited by this paper
• Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening

  1997cited by this paper
• Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice.

  1997cited by this paper
• Colorectal cancer screening: clinical guidelines and rationale.

  1997cited by this paper
• Functional and clinical aspects of the myelomonocyte protein calprotectin.

  1997cited by this paper
• Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces

  1996cited by this paper
• Randomised study of screening for colorectal cancer with faecal-occult-blood test.

  1996cited by this paper
• Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool.

  1996cited by this paper
• Detection of K‐ras mutations in stools of patients with colorectal cancer by mutant‐enriched PCR

  1996cited by this paper
• Mutations of the p53 gene in the stool of patients with resectable colorectal cancer

  1996cited by this paper
• Fecal alpha 1-antitrypsin detection of colorectal neoplasia. An evaluation using HemoQuant.

  1995cited by this paper
• Inhibition of apoptosis during development of colorectal cancer.

  1995cited by this paper
• Evaluation and comparison of an immunochemical and a guaiac faecal occult blood screening test for colorectal neoplasia

  1995cited by this paper
• Fecal marker variability in colorectal cancer: calprotectin versus hemoglobin.

  1995cited by this paper
• The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces.

  1995cited by this paper
• Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer.

  1995cited by this paper
• Intestinal protein loss and bleeding assessed by fecal hemoglobin, transferrin, albumin, and alpha-1-antitrypsin levels in patients with colorectal diseases.

  1995cited by this paper
• Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients.

  1995cited by this paper
• Increased expression of CD44 in isolated fecal colonocytes in patients with colonic neoplasia

  1995cited by this paper
• Fecal α1-antitrypsin detection of colorectal neoplasia

  1995cited by this paper
• Mutations in the APC gene and their implications for protein structure and function.

  1995cited by this paper
• A method for preparation of fecal DNA suitable for PCR.

  1995cited by this paper
• Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon.

  1995cited by this paper
• Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).

  1995cited by this paper
• A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from bovine faeces.

  1994cited by this paper
• [Measurement of fecal hemoglobin-haptoglobin complex as a new diagnostic tool of lower gastrointestinal tract diseases].

  1994cited by this paper
• Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.

  1994cited by this paper
• Reliability of PCR directly from stool samples: usefulness of an internal standard.

  1994cited by this paper
• Faecal calprotectin: a novel test for the diagnosis of colorectal cancer?

  1993cited by this paper
• Estimates of the worldwide incidence of eighteen major cancers in 1985

  1993cited by this paper
• Detection of Colorectal Cancer by Faecal α1-Antitrypsin

  1993cited by this paper
• Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history.

  1993cited by this paper
• Detection of colorectal cancer by faecal alpha 1-antitrypsin.

  1993cited by this paper
• Immunological determination of fecal hemoglobin and transferrin levels: a comparison with other fecal occult blood tests.

  1992cited by this paper
• Isolation of exfoliated colonic epithelial cells, a novel, non‐invasive approach to the study of cellular markers

  1992cited by this paper
• p53, guardian of the genome

  1992cited by this paper
• APC mutations occur early during colorectal tumorigenesis

  1992cited by this paper
• Detection of fecal blood by colloidal gold agglutination using an anti-human hemoglobin monoclonal antibody.

  1992cited by this paper
• Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene.

  1992cited by this paper
• Cancer. p53, guardian of the genome.

  1992cited by this paper
• Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.

  1992cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper
• Colon cancer and dietary fiber: cellulose inhibits the DNA-damaging ability of bile acids.

  1990cited by this paper
• Faecal occult blood screening for colorectal neoplasia: A randomized trial of three days or six days of tests

  1990cited by this paper
• Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin.

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Allelotype of colorectal carcinomas.

  1989cited by this paper
• [A new latex agglutination test for the immunologic detection of occult blood in stool].

  1989cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• ras GTPase activating protein: signal transmitter and signal terminator.

  1989cited by this paper

• Genomic and functional characterization of a mucosal symbiont involved in early-stage colorectal cancer.

  2021cites this paper
• The arrow of carcinogenesis

  2018cites this paper
• Genetic and epigenetic markers in colorectal cancer screening: recent advances

  2017cites this paper
• Present Situation and Prospect of Diagnosis and Treatment of Colorectal Cancer

  2017cites this paper
• A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer

  2016cites this paper
• Lack of association between human papillomavirus infection and colorectal cancer

  2014cites this paper
• OPTIMIZACIÓN DE UNA TÉCNICA PARA LA EXTRACCIÓN DE ADN DE HECES DE VICUÑA (Vicugna vicugna mensalis)

  2012cites this paper
• Update on colorectal cancer imaging.

  2012cites this paper
• Fecal Molecular Markers for Colorectal Cancer Screening

  2011cites this paper
• FluSiM Simulation for Malaysia: Toward sImproved Pandemic Surveillance

  2011cites this paper
• Toward Standardized High-Throughput Serum Diagnostics

  2011cites this paper
• Screening for colorectal cancer.

  2011cites this paper
• DEVELOPMENT AND COMMERCIALIZATION OF A FECAL DNA BASED MOLECULAR DIAGNOSTIC ASSAY FOR COLORECTAL CANCER SCREENING

  2010cites this paper
• Genetic and Epigenetic Marker-Based DNA Test of Stool Is a Promising Approach for Colorectal Cancer Screening

  2009cites this paper
• Metabolite profiling of fecal water extracts from human colorectal cancer

  2009cites this paper
• An Overview of Colorectal Cancer Screening

  2008cites this paper
• Infectious Agents and Colorectal Cancer: A Review of Helicobacter pylori, Streptococcus bovis, JC Virus, and Human Papillomavirus

  2008cites this paper
• The law of unintended consequences: The Joint Commission regulations and the digital rectal examination.

  2008cites this paper
• Serumtest für C3a Anaphylatoxin ermöglicht minimal-invasives Screening für kolorektale Tumoren

  2008cites this paper
• From screening criteria to colorectal cancer screening: what can New Zealand learn from other countries?

  2008cites this paper
• Faecal screening of colorectal cancer

  2007cites this paper
• From the genome to the proteome—biomarkers in colorectal cancer

  2007cites this paper
• From genome to proteome in tumor profiling: molecular events in colorectal cancer genesis.

  2006cites this paper
• Molecular stool testing for the early detection of colorectal cancer: swan song for p53?

  2006cites this paper
• Using p53-immunostained large specimens to determine the distal intramural spread margin of rectal cancer.

  2006cites this paper
• Ultrasonography in diagnosing colorectal cancers in patients presenting with abdominal distension

  2006cites this paper
• SELDI-TOF Massen-Spektrometrie ermöglicht die Erkennung von Serum Markern für kolorektale Karzinome

  2006cites this paper
• Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors.

  2006cites this paper
• Familial colorectal cancer referral to regional genetics department—a single centre experience

  2006cites this paper
• Screening for colorectal cancer

  2005cites this paper
• Screening for colorectal cancer

  2002cites this paper